Drug Discovery World

APRIL 14, 2023

Doctors said not to worry. She is also an investigator with the Howard Hughes Medical Institute. Wherry’s award lecture will be held on Monday April 17 at 3:30pm ET. Simon’s award lecture will be held on Sunday April 16 at 3pm ET. Delattre’s award lecture will be held on Tuesday April 18 at 5pm ET.

Clinical Trials 130

Clinical Trials Research Science Clinical Research 130

Agency IQ

SEPTEMBER 15, 2023

Until recently, the FDA relied on a monograph process through which firms could bring OTC drugs to market without FDA approval so long as it adhered to pre-set terms under the monograph. Overall, 2022 phenylephrine retail sales reached $1.8 billion, compared with retail sales of $0.5 billion for pseudoephedrine.

Science 40

Science FDA Clinical Trials Pharmacy 40

Drug & Device Law

JULY 24, 2023

2022) (many other cases recognize this problem with class actions). the relationship between [plaintiff] and its pharmacy benefit manager. . . Apparently, massive loss of evidence was merely a “usual and customary service” of pharmacy benefit mangers nationwide. E.g. , Laudato v. EQT Corp. , 4th 256, 260 (3d Cir. 555, 565 (E.D.

Testimonials 52

Testimonials Pharmacy FDA Doctors 52

Drug & Device Law

DECEMBER 29, 2023

As a matter of science, the purported link was imaginary, as discussed at great length in one of the many excellent Zantac ( 2022+4 ) MDL opinions. Legally the State of California – or, more accurately, a private litigant purporting to exercise state powers – has no such power, because warnings on OTC drugs must be approved by the FDA.

Testimonials 105

Testimonials FDA Drugs Vaccine 105